Literature DB >> 7883975

Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heart.

P Ping1, R Gelzer-Bell, D A Roth, D Kiel, P A Insel, H K Hammond.   

Abstract

To determine whether beta-adrenergic receptor agonist activation influences guanosine 5'-triphosphate-binding protein (G-protein) expression and beta-adrenergic receptor kinase activity in the heart, we examined the effects of chronic beta 1-adrenergic receptor antagonist treatment (bisoprolol, 0.2 mg/kg per d i.v., 35 d) on components of the myocardial beta-adrenergic receptor-G-protein-adenylyl cyclase pathway in porcine myocardium. Three novel alterations in cardiac adrenergic signaling associated with chronic reduction in beta-adrenergic receptor agonist activation were found. First, there was coordinate downregulation of Gi alpha 2 and Gs alpha mRNA and protein expression in the left ventricle; reduced G-protein content was also found in the right atrium. Second, in the left ventricle, there was a twofold increase in beta-adrenergic receptor-dependent stimulation of adenylyl cyclase and a persistent high affinity state of the beta-adrenergic receptor. Finally, there was a reduction in left ventricular beta-adrenergic receptor kinase activity, suggesting a previously unrecognized association between the degree of adrenergic activation and myocardial beta-adrenergic receptor kinase expression. The heart appears to adapt in response to chronic beta-adrenergic receptor antagonist administration in a manner that would be expected to offset reduced agonist stimulation. The mechanisms for achieving this extend beyond beta-adrenergic receptor upregulation and include alterations in G-protein expression, beta-adrenergic receptor-Gs interaction, and myocardial beta-adrenergic receptor kinase activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883975      PMCID: PMC441466          DOI: 10.1172/JCI117777

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Rapid agonist-induced beta-adrenergic receptor kinase translocation in C6 glioma cells.

Authors:  I García-Higuera; F Mayor
Journal:  FEBS Lett       Date:  1992-05-04       Impact factor: 4.124

Review 2.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  A substantial proportion of cardiac Gs is not associated with the plasma membrane.

Authors:  D A Roth; K Urasawa; D Leiber; P A Insel; H K Hammond
Journal:  FEBS Lett       Date:  1992-01-13       Impact factor: 4.124

4.  Noncoordinate regulation of cardiac Gs protein and beta-adrenergic receptors by a physiological stimulus, chronic dynamic exercise.

Authors:  H K Hammond; L A Ransnas; P A Insel
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 5.  Structure and mechanism of the G protein-coupled receptor kinases.

Authors:  J Inglese; N J Freedman; W J Koch; R J Lefkowitz
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

6.  Diverse G protein and beta-adrenergic receptor mRNA expression in normal and failing porcine hearts.

Authors:  P Ping; H K Hammond
Journal:  Am J Physiol       Date:  1994-11

7.  Transcription program of the chloroplast genome of Euglena gracilis during chloroplast development.

Authors:  B K Chelm; R B Hallick; P W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

8.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

9.  Myocardial beta-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion.

Authors:  H K Hammond; D A Roth; P A Insel; C E Ford; F C White; A S Maisel; M G Ziegler; C M Bloor
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

10.  Myocardial adrenergic denervation supersensitivity depends on a postreceptor mechanism not linked with increased cAMP production.

Authors:  H K Hammond; D A Roth; C E Ford; G W Stamnas; M G Ziegler; C Ennis
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

View more
  17 in total

Review 1.  Myocardial gene transfer.

Authors:  D C White; W J Koch
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

2.  Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer.

Authors:  S A Akhter; C A Skaer; A P Kypson; P H McDonald; K C Peppel; D D Glower; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation.

Authors:  S Nagaraja; S Iyer; X Liu; J Eichberg; R A Bond
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 4.  Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure.

Authors:  Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-11       Impact factor: 3.000

Review 5.  Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice.

Authors:  H A Rockman; W J Koch; C A Milano; R J Lefkowitz
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

6.  Selective beta1-adrenoceptor blockade enhances the activity of the stimulatory G-protein in human atrial myocardium.

Authors:  T Wang; C Plumpton; M J Brown
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

7.  Up-regulation of H2 receptor and adenylate cyclase in rabbit parietal cells during prolonged treatment with H2-receptor antagonists.

Authors:  K Takeuchi; M Kajimura; M Kodaira; S Lin; H Hanai; E Kaneko
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

Review 8.  Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation.

Authors:  Neil J Freedman; Robert J Lefkowitz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Enhancement of the recycling and activation of beta-adrenergic receptor by Rab4 GTPase in cardiac myocytes.

Authors:  Catalin M Filipeanu; Fuguo Zhou; May L Lam; Kenneth E Kerut; William C Claycomb; Guangyu Wu
Journal:  J Biol Chem       Date:  2006-02-16       Impact factor: 5.157

10.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.

Authors:  H A Rockman; K R Chien; D J Choi; G Iaccarino; J J Hunter; J Ross; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.